Key takeaways
- • Severity: No clinically significant interaction known.
- • Zepbound (weight management (FDA-approved obesity)) and Apixaban (Eliquis) (DOAC (anticoagulant)).
- • Clinical management: No dose adjustment required. Defer dosing decisions to the prescriber.
- • Monitoring: Standard monitoring per apixaban prescribing information (renal function, signs of bleeding).
Mechanism
No known clinically significant interaction. Apixaban is metabolized via CYP3A4 and is a P-gp/BCRP substrate; tirzepatide does not affect these pathways. DOACs have predictable dose-response and don't require routine monitoring, so minor absorption shifts are clinically irrelevant.
Clinical management
No dose adjustment required. Defer dosing decisions to the prescriber.
GLP1Zoom does not prescribe medications or recommend dose changes. Always confirm any adjustment with your prescribing clinician before changing how you take Zepbound or Apixaban (Eliquis).
Monitoring
Standard monitoring per apixaban prescribing information (renal function, signs of bleeding).
When to call your doctor
- Unusual bruising or bleeding
- Bloody or black stools
- Pink or red urine
In emergencies — severe abdominal pain, persistent vomiting, fainting, signs of severe hypoglycemia (confusion, seizures), or signs of bleeding — call 911 or go to the nearest emergency department.
Source / FDA label citation
Not specifically listed in current FDA label
Editorial confidence: 8/10. Lower scores reflect inferred mechanism rather than directly-labeled interaction. We re-verify against the active FDA prescribing information at least every 6 months.
Common questions
Can I take Apixaban (Eliquis) with Zepbound?
Apixaban (Eliquis) and Zepbound have no clinically significant interaction documented. Standard prescribing applies. Always confirm with your prescriber, since individual medical history can change the calculation.
What's the mechanism of any Zepbound + Apixaban (Eliquis) interaction?
No known clinically significant interaction. Apixaban is metabolized via CYP3A4 and is a P-gp/BCRP substrate; tirzepatide does not affect these pathways. DOACs have predictable dose-response and don't require routine monitoring, so minor absorption shifts are clinically irrelevant.
What should I monitor when on Zepbound + Apixaban (Eliquis)?
Standard monitoring per apixaban prescribing information (renal function, signs of bleeding).
When should I call my doctor?
Contact your prescriber if you notice any of: Unusual bruising or bleeding; Bloody or black stools; Pink or red urine.
Related
This page summarizes general pharmacology from FDA-approved prescribing information. It is not a substitute for personalized medical advice. GLP1Zoom is an affiliate-only comparator — we do not prescribe or sell medications. Full disclaimer.